FULGENT THERAPEUTICS LLC
The Assay Development Technologist is a cross-functional role focused on driving decision-making and data-driven product development for molecular biology assays. The position involves designing, developing, and validating fully automated, high-throughput genetic tests from concept through commercial launch. This role emphasizes creating a collaborative environment while integrating cutting-edge technology into laboratory processes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for FULGENT THERAPEUTICS LLC.
FULGENT THERAPEUTICS LLC didn’t post a salary, so this is our estimate from similar listings.